Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Jazz Pharmaceuticals PLC (JAZZ) had Return on Equity of -0.40% for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$901.98M |
|
$-14.62M |
|
$95.49M |
|
$806.50M |
|
$835.78M |
|
$66.21M |
|
$-67.81M |
|
$-1.60M |
|
$-1.60M |
|
$-13.27M |
|
$-14.62M |
|
$-14.62M |
|
$-13.27M |
|
$66.21M |
|
$229.59M |
|
62.54M |
|
62.54M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$3.54B |
|
$166.24M |
|
$7.79B |
|
$11.33B |
|
$1.56B |
|
$5.11B |
|
$6.07B |
|
$7.63B |
|
$3.70B |
|
$-3.28B |
|
$3.70B |
|
63.03M |
|
| Cash Flow Statement Financials | |
$267.23M |
|
$-271.90M |
|
$-56.55M |
|
$1.51B |
|
$1.44B |
|
$-62.92M |
|
$61.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.27 |
|
-- |
|
-- |
|
0.58 |
|
1.54 |
|
89.41% |
|
7.34% |
|
7.34% |
|
-- |
|
-0.18% |
|
-1.62% |
|
$260.32M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.17 |
|
1.28 |
|
70.55 |
|
|
Return on Equity |
-0.40% |
0.45% |
|
-0.13% |
|
-0.17% |
|
$58.65 |
|
$4.16 |
|
$4.27 |
|